Skip to main content
. Author manuscript; available in PMC: 2018 Apr 15.
Published in final edited form as: Bioorg Med Chem Lett. 2017 Mar 10;27(8):1744–1749. doi: 10.1016/j.bmcl.2017.02.070

Figure 1.

Figure 1

8f inhibits bleomycin-induced skin fibrosis in mice. Three groups of mice (n=8) were treated for 14 days with one of the following daily protocols: Control: intracutaneous injections of PBS; Bleo: intracutaneous injections of bleomycin with concurrent oral gavage of vehicle; or Bleo + 8f: intracutaneous injections of bleomycin with concurrent oral gavage of 50 mg/kg 8f.